Publication Name	World Journal of Radiology
Manuscript ID	3043
Country	Germany

Received	2013-04-04 20:26
Peer-Review Started	2013-04-05 01:03
To Make the First Decision	2013-05-02 09:00
Return for Revision	2013-05-13 15:31
Revised	2013-05-23 04:04
Second Decision	2013-07-05 10:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-07-05 12:48
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-07-17 17:45
Publish the Manuscript Online	2013-08-02 13:56

ISSN	1949-8470 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type	Autobiography
Article Title	Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?
Manuscript Source	Invited Manuscript
All Author List	Matthias C Roethke, Timur H Kuru, Alexander Radbruch, Boris Hadaschik and Heinz-Peter Schlemmer
Funding Agency and Grant Number
Corresponding Author	Dr. Matthias C Roethke, MD, Department of Radiology, German Cancer Research Center Heidelberg (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. m.roethke@dkfz-heidelberg.de
Key Words	Butylscopolamine; Buscopan; Motion artefacts; Magnetic resonance imaging; Prostate cancer; 3 Tesla
Core Tip	The study demonstrated no significant effect of hyoscine-N-butyl-bromide (HBB) (butylscopolamine) administration on image quality of prostate magnetic resonance imaging (MRI) at 3.0 Tesla without using an endorectal coil. The results suggest that the use of HBB is not generally mandatory for MRI of the prostate.
Publish Date	2013-08-02 13:56
Citation	Roethke MC, Kuru TH, Radbruch A, Hadaschik B, Schlemmer HP. Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory? World J Radiol 2013; 5(7): 259-263
URL	http://www.wjgnet.com/1949-8470/full/v5/i7/259.htm
DOI	http://dx.doi.org/10.4329/wjr.v5.i7.259

Full Article (PDF)	WJR-5-259.pdf
Manuscript File	3043-Review.doc
Answering Reviewers	3043-Answering reviewers.pdf
Copyright License Agreement	3043-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	3043-Language certificate.pdf
Peer-review Report	3043-Peer reviews.pdf
Scientific Editor Work List	3043-Scientific editor work list.doc